Garvan Institute of Medical Research

HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer

Rasiah, K.K.; Gardiner-Garden, M.; Padilla, E.J.D.; Mller G.; Kench, J.G.; Alles, C.M.; Eggleton, S.A.; Stricker, P.D.; Adamski, J.; Sutherland, R.L.; Henshall, S.M.; Hayes, V.M.

MOLECULAR AND CELLULAR ENDOCRINOLOGY 301 (1-2) :89-96, 2009 10.1016/j.mce.2008.11.021

No association between common chemokine and chemokine receptor gene variants and prostate cancer risk.

Petersen, D.C., Severi, G., Hoang, H.N., Carr, E.J.D., Southey, M.C., English, D.R., Hopper, J.L., Giles, G.G.; Hayes, V.M.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 7 (12) :3615-3617, 2008 10.1158/1055-9965.EPI-08-0896

The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels

Severi, G.;Hayes, V. M.;Tesoriero, A. A.;Southey, M. C.;Hoang, H. N.;Padilla, E. J.;Morris, H. A.;English, D. R.;Sutherland, R. L.;Boyle, P.;Hopper, J. L.;Giles, G. G. :

BJU International 101 (4) :492-6, 2008

5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia

Hayes, V. M.;Severi, G.;Padilla, E. J.;Morris, H. A.;Tilley, W. D.;Southey, M. C.;English, D. R.;Sutherland, R. L.;Hopper, J. L.;Boyle, P.;Giles, G. G. :

INTERNATIONAL JOURNAL OF CANCER 120 (4) :776-80, 2007

Novel Plexor SNP genotyping technology: comparisons with TaqMan and homogenous MassEXTEND MALDI-TOF mass spectrometry

Tindall, E. A.;Speight, G.;Petersen, D. C.;Padilla, E. J.;Hayes, V. M. :

HUMAN MUTATION 28 (9) :922-7, 2007

The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study

Severi, G.;Hayes, V. M.;Padilla, E. J.;English, D. R.;Southey, M. C.;Sutherland, R. L.;Hopper, J. L.;Giles, G. G. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 16 (3) :610-2, 2007

Mammographic density and candidate gene variants: a twins and sisters study

Stone, J.;Gurrin, L. C.;Byrnes, G. B.;Schroen, C. J.;Treloar, S. A.;Padilla, E. J.;Dite, G. S.;Southey, M. C.;Hayes, V. M.;Hopper, J. L. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 16 (7) :1479-84, 2007

Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha

Yang, J. L.; Qu, X. J.; Hayes, V. M.; Brenner, P. C.; Russell, P. J.; Goldstein, D.

BJU International 99 (6) :1539-45, 2007

Review of: A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting

Hayes, V. M. :

Breast Cancer Online (BCO) www.bco.org (10) :e00 (pages 1 of 3), 2007

Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival

Hayes, V. M.;Severi, G.;Southey, M. C.;Padilla, E. J.;English, D. R.;Hopper, J. L.;Giles, G. G.;Sutherland, R. L. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 15 (6) :1223-5, 2006

Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein

Brummer, T.;Schramek, D.;Hayes, V. M.;Bennett, H. L.;Caldon, C. E.;Musgrove, E. A.;Daly, R. J. :

JOURNAL OF BIOLOGICAL CHEMISTRY 281 (1) :626-37, 2006

Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA

Severi, G.;Hayes, V. M.;Neufing, P.;Padilla, E. J.;Tilley, W. D.;Eggleton, S. A.;Morris, H. A.;English, D. R.;Southey, M. C.;Hopper, J. L.;Sutherland, R. L.;Boyle, P.;Giles, G. G. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 15 (6) :1142-7, 2006

The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia

Hayes, V. M.;Severi, G.;Eggleton, S. A.;Padilla, E. J.;Southey, M. C.;Sutherland, R. L.;Hopper, J. L.;Giles, G. G. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 14 (4) :993-6, 2005

Review of: Association of cyclin D1 genotype with breast cancer risk and survival.

Hayes, V. M. :

Breast Cancer Online (BCO) www.bco.org 2005

Genetic variants in the vitamin D receptor gene and prostate cancer risk

Hayes, V. M.;Severi, G.;Padilla, E. J.;Eggleton, S. A.;Southey, M. C.;Sutherland, R. L.;Hopper, J. L.;Giles, G. G. :

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 14 (4) :997-9, 2005

Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population

Petersen, D. C.;Glashoff, R. H.;Shrestha, S.;Bergeron, J.;Laten, A.;Gold, B.;van Rensburg, E. J.;Dean, M.;Hayes, V. M. :